Current Studies

CCST are currently conducting a number of studies requiring healthy volunteers and patient subjects. Some examples are below:

• A single oral ascending dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an IMP in healthy subjects, including the effect of food, activated charcoal, formulation and intravenous micro-dosing.
• A randomised, parallel-group, dose-ranging study to evaluate efficacy, safety, pharmacokinetics and antiviral activity of an IMP and existing products in patient subjects with chronic hepatitis C.
• A randomised, double-blind, placebo controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokenetics and pharmacodynamics of an IMP in healthy subjects and subjects with Psoriasis.  
• A phase one placebo controlled, randomised, double-blind combined single and multiple asscending dose study to investigate the safety, tolerability, pharmacokenetics and pharmacodynamics of an IMP in healthy subjects.
• A phase two, multicentre, double-blinded, placebo controlled, multiple dose study to evaluate safety, tolerability, efficacy, pharmacokenetics and pharmacodynamics of an IMP alone and in combination with an existing product in subjects with Cystic Fibrosis.  

If you are interested in any of these studies please contact CCST.

VOLUNTEERS - REGISTER TODAY!